Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents...
Chenia Lloyd-Gascho, who was diagnosed with Li-Fraumeni syndrome when he was 8 years old, shared what it is like...
Melanoma expert Ashani T. Weeraratna, PhD, of Johns Hopkins Bloomberg School of Public Health, explains how bemotrizinol—the first new...
At the AACR Annual Meeting 2026, we conducted "Bite-sized Research" interviews with attendees for morsels of knowledge about their...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...
At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people...
The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology...
In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and...
In February, AACR partnered with the Instituto Nacional de Cancerología and Fundación Valle del Lili for two AACR on...
In the CAR-PRISM clinical trial, the CAR T-cell therapy ciltacabtagene autoleucel showed promise for treating high-risk smoldering myeloma.